Patents
Literature
1 results about "Atovaquone" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Atovaquone is used to prevent or treat a serious lung infection called Pneumocystis pneumonia (PCP).
Mitochondria-targeted atovaquone: a more potent and more effective antitumor, antimicrobial, and antimalarial drug
PendingUS20260174785A1Group 5/15 element organic compoundsPhosphorous compound active ingredientsAntibiosisAtovaquone
The present invention provides novel mitochondria-targeted Atovaquone compounds (Mito-ATO), a mitochondria-targeted derivative of Atovaquone, and methods of using such compounds. Methods of treating cancer using mito-ATO are also provided. Methods of enhancing an anti-tumor immune response by administering mito-ATO are further provided.
Owner:MEDICAL COLLEGE OF WISCONSIN INC +1